Inspiren banks $35M to scale AI-powered senior living technology
Posted:
Health tech company Inspiren developed intelligent AI-powered solutions for senior living that integrates care planning, resident safety, staff efficiency and emergency call functionalities into one system.
The Food and Drug Administration approved a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease that leaves children vulnerable to life-threatening infections.
Read more here.
OpenAI launched ChatGPT Health and Anthropic added medical toolsets for Claude, meaning users can sync their records and wearables, using their personal health data to get hyper-specific answers to their medical questions. At the same time, the FDA issued new guidance…
Attendees
Sponsors and Exhibitors
Contact us